Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice

      , , , ,
      Biochemical Pharmacology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="P2">Cholinergic signaling via the nicotinic acetylcholine receptors (nAChRs) in the mesolimbic circuitry is involved in the rewarding effects of abused drugs such as cocaine and opioids. In mouse studies, nonselective nAChR antagonist mecamylamine blocks cocaine-induced conditioned place preference (CPP) and behavioral sensitization. Among subtype-selective nAChR antagonists, the β2-selective antagonist dihydrobetaerythroidine and α7 nAChR antagonist methyllycaconitine (MLA), but not MLA alone prevent behavioral sensitization to cocaine. Since the role of the α3β4 nAChR subtype in the rewarding and behavioral effects of cocaine is unknown, the present study investigated the effect of two potent and selective α3β4 nAChR ligands, AT-1001 and AT-1012, on the acquisition of cocaine-induced CPP and behavioral sensitization in mice. At 5–30 mg/kg, cocaine produced robust CPP, whereas behavioral sensitization of locomotor activity was only observed at the higher doses (20–30 mg/kg). Pretreatment with AT-1001 (1–10 mg/kg) or AT-1012 (3–10 mg/kg) blocked CPP induced by 5 mg/kg cocaine, but not by 30 mg/kg cocaine. Lower doses of AT-1001 (0.3–3 mg/kg) and AT-1012 (1–3 mg/kg) did not affect the increase in locomotor activity induced by 5 or 30 mg/kg cocaine. But AT-1001, at these doses, blocked locomotor sensitization induced by 30 mg/kg cocaine. These results indicate that the α3β4 nAChR play a role in the rewarding and behavioral effects of cocaine, and that selective α3β4 nAChR ligands can attenuate cocaine-induced behavioral phenomena. Since the selective α3β4 nAChR functional antagonist AT-1001 has also been shown to block nicotine self-administration in rats, the present results suggest that α3β4 nAChRs may be a target for the treatment of cocaine addiction as well as for cocaine-nicotine comorbid addiction. </p><p id="P3"> <div class="figure-container so-text-align-c"> <img alt="" class="figure" src="/document_file/a78cef4d-a07e-4146-8b88-5ab719f0346f/PubMedCentral/image/nihms719410u1.jpg"/> </div> </p>

          Related collections

          Author and article information

          Journal
          Biochemical Pharmacology
          Biochemical Pharmacology
          Elsevier BV
          00062952
          October 2015
          October 2015
          : 97
          : 4
          : 531-541
          Article
          10.1016/j.bcp.2015.08.083
          4600456
          26256075
          5ae8acbb-9247-4dfd-a2c4-6df16a199e4c
          © 2015

          http://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article